Skip to content

Understanding What a Pink Pill with NGL on It Is

4 min read

According to Drugs.com, a pink, oval pill imprinted with 'nGL 25' is identified as Movantik 25 mg. This medication contains the active ingredient naloxegol and is used to treat a specific type of chronic constipation. The imprint on a pill is a crucial piece of information for proper identification, ensuring safety and preventing mix-ups.

Quick Summary

A pink, oval pill marked with 'nGL 25' is the medication Movantik, containing naloxegol 25 mg. It is a prescription-only drug for adults experiencing chronic constipation caused by opioid pain medications. The article covers its mechanism, proper use, potential side effects, and important drug interactions.

Key Points

  • Identity of the Pill: A pink, oval tablet with 'nGL 25' imprinted on it is the prescription medication Movantik 25 mg, containing the active ingredient naloxegol.

  • Medical Use: Movantik is a medication specifically prescribed to treat opioid-induced constipation in adults with chronic non-cancer pain.

  • Mechanism of Action: Naloxegol works by blocking opioid receptors in the gut, which helps reverse the constipating effects of opioid pain medication without affecting pain relief in the brain.

  • Administration: Movantik is taken orally once daily on an empty stomach, at least one hour before or two hours after eating.

  • Important Warnings: Serious side effects like severe gastrointestinal issues can occur, and the medication should not be used by individuals with a bowel obstruction.

  • Drug Interactions: Patients must avoid grapefruit and grapefruit juice, and inform their doctor of all other medications to prevent harmful interactions.

  • Identification Caution: Always use a reliable pill identifier and consult a healthcare professional to confirm a medication's identity; do not ingest unknown pills.

In This Article

What is a pink pill with nGL 25 on it?

A pink, oval tablet with the imprint 'nGL 25' is the brand-name prescription medication Movantik (naloxegol) 25 mg. The identification is critical because a similar imprint, 'nGL 12.5', is for the same drug but a different dosage and color (purple). This pill is prescribed specifically for adults suffering from opioid-induced constipation (OIC). It is not a traditional laxative but a targeted treatment designed to counteract the constipating effects of opioid pain medication.

Pharmacology of Naloxegol (Movantik)

Naloxegol belongs to a class of drugs known as peripherally acting mu-opioid receptor antagonists (PAMORAs). To understand how it works, it is important to know that opioids bind to mu-opioid receptors throughout the body, including in the central nervous system (CNS) to produce pain relief and in the gastrointestinal (GI) tract, which causes constipation.

Unlike traditional opioid antagonists like naloxone, which can reverse both central and peripheral opioid effects, naloxegol is designed to primarily block the opioid receptors in the gut. Because naloxegol has a low ability to cross the blood-brain barrier, it can effectively alleviate constipation without interfering with the pain-relieving effects of the opioid medication in the CNS.

Uses and Indications

Movantik is used to treat opioid-induced constipation in adults with chronic non-cancer pain. It is important to note that it is not intended for use in patients with constipation not caused by opioids. The medication is taken orally and acts within the intestines to help restore normal bowel function.

Administration and Dosage

  • Dosage: Movantik is available in different strengths, and a healthcare professional will determine the appropriate dosage for each individual.
  • Timing: The tablet should be taken on an empty stomach, at least one hour before or two hours after the first meal of the day.
  • Swallowing: Swallow the tablet whole. Do not crush, break, or chew it. If swallowing is difficult, you can crush the tablet and mix it with water.
  • Discontinuation: If you stop taking opioid pain medication, you should also stop taking Movantik.

Important Safety Information and Drug Interactions

Like all medications, Movantik can have side effects and interacts with other substances. Patients should be aware of potential issues, and their doctor will provide a Medication Guide.

Potential Side Effects

Common side effects of naloxegol include:

  • Stomach pain
  • Diarrhea
  • Nausea
  • Gas
  • Headache
  • Sweating and chills (potential signs of withdrawal)

Serious Side Effects

Contact a doctor immediately if you experience serious side effects, such as:

  • Severe or worsening stomach pain and diarrhea, which could signal a serious gastrointestinal issue like a tear or perforation.
  • Symptoms of opioid withdrawal, such as anxiety, irritability, and sweating.
  • Signs of an allergic reaction, including rash, hives, or swelling of the face, tongue, or throat.

Drug Interactions and Contraindications

  • CYP3A4 Inhibitors: Certain medications that affect the enzyme CYP3A4, such as clarithromycin and itraconazole, can interact with naloxegol and may require a dosage adjustment.
  • Grapefruit: Do not consume grapefruit or grapefruit juice while taking Movantik, as it can increase the drug's concentration and risk of side effects.
  • Gastrointestinal Obstruction: Patients with a known or suspected gastrointestinal obstruction should not take Movantik.

Movantik vs. Other Constipation Treatments

Feature Movantik (Naloxegol) Traditional Stimulant Laxatives (e.g., Bisacodyl) Other PAMORAs (e.g., Relistor - Methylnaltrexone)
Mechanism Targets peripheral mu-opioid receptors in the gut to counteract opioid-induced constipation. Stimulates the nerves in the intestines to increase bowel movements. Also a PAMORA, blocks opioid receptors in the gut, similar action to Movantik.
Indication Specifically treats opioid-induced constipation in adults with chronic non-cancer pain. Treats various forms of short-term constipation. Treats opioid-induced constipation, but available as an oral tablet and an injection.
Effect on Pain Relief Does not interfere with the pain-relieving effects of opioids in the brain. No effect on opioid analgesia. Does not affect opioid pain relief.
Administration Oral tablet, taken once daily on an empty stomach. Oral tablet, typically taken as needed for constipation. Oral tablet or subcutaneous injection.
Considerations Requires a prescription. Potential for severe GI issues, especially with pre-existing conditions. Available over-the-counter. Long-term use can lead to dependency. Requires a prescription. Has similar side effects and indications.

How to safely identify your medication

If you find an unidentified pill, it is crucial to use a reliable pill identification tool and follow safety precautions. Always consult a healthcare professional or pharmacist to confirm the identity of any medication. Online resources like Drugs.com and the FDA's databases are valuable tools.

Steps to take:

  1. Do not ingest the pill. Never take a medication you cannot positively identify.
  2. Use the imprint code. The 'nGL 25' marking is the most important identifier. The shape and color (pink, oval) are also key.
  3. Compare with an image. Look up the pill using an online pill identifier and compare your pill with the image provided.
  4. Check with your pharmacist. A pharmacist can confirm the medication using the imprint code and your prescription history.
  5. Consider safe disposal. If you are still unsure or the medication is old, dispose of it properly according to local guidelines.

Conclusion

The pink pill with 'nGL 25' on it is the brand-name prescription medication Movantik (naloxegol), used to treat opioid-induced constipation. Its specific mechanism of action allows it to alleviate constipation without compromising the central pain-relieving effects of opioid medication. Proper administration and awareness of potential side effects and drug interactions, particularly with grapefruit and other medications, are essential for its safe and effective use. When identifying unknown pills, always rely on professional resources and never self-medicate.


Authoritative Outbound Link: MedlinePlus - Naloxegol

Frequently Asked Questions

Movantik is a prescription medication containing the active ingredient naloxegol, a peripheral opioid receptor antagonist, used to treat constipation caused by opioid pain medications.

Movantik should be taken on an empty stomach, either at least one hour before or two hours after your first meal of the day. The tablets should be swallowed whole.

Common side effects include stomach pain, diarrhea, nausea, gas, and headache. In some cases, mild opioid withdrawal symptoms may also occur.

Individuals with a known or suspected gastrointestinal obstruction should not take Movantik. Patients with certain medical conditions or who are taking interacting medications may also need dosage adjustments.

No, you should not eat grapefruit or drink grapefruit juice while taking Movantik. Grapefruit can increase the levels of naloxegol in your body and increase the risk of side effects.

If you find an unknown pill, do not take it. Use a reliable pill identification tool online or consult your pharmacist. Always prioritize safety and confirm medication identity with a healthcare professional.

Movantik is not a traditional laxative. It is a targeted treatment that works by blocking opioid receptors in the gut to counteract constipation caused by opioid pain medications.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.